January 2024
-
01.09.2024 Updates & Statements Albert Bourla History Leadership Medicines Vaccines CEO Albert Bourla Kicks Off Pfizer’s 175th Anniversary Celebration
December 2023
-
12.29.2023 Updates & Statements Albert Bourla Covid-19 Leadership Oncology Rare Diseases December Social Media Round-Up—Welcome Seagen, US/India CEO Forum, AI, and Gratitude -
12.28.2023 Events Health Equity Partnerships Vaccines Wellness The Stars Come Out for Pfizer-Sponsored “Divas Simply Singing!” Benefit Concert -
12.22.2023 Updates & Statements Responsibility Pfizer Accelerates Climate Action through Pan-European Virtual Power Purchase Power Agreements -
12.15.2023 Updates & Statements Covid-19 Diseases & Conditions Influenza Pneumoccocal Disease Pneumonia Respiratory Syncytial Virus Technology Pfizer Launches VaxAssist, to Help Individual’s Assess Respiratory Vaccine Eligibility -
12.06.2023 Events Blood Cancer Diseases & Conditions Hemophilia Medicines Rare Diseases Research ASH 2023: Advancing Potential Breakthroughs for Patients with Hematologic Disorders -
12.04.2023 Updates & Statements Albert Bourla Covid-19 Diversity & Inclusion Leadership November Social Media Round-Up—Vaccine Anniversary, Transgender Awareness, and the Corporate Equality Index
November 2023
-
11.29.2023 Updates & Statements Covid-19 Diseases & Conditions Medicines Wellness Pfizer’s 2-in 1 At-Home Test Enables Convenient Testing for both COVID-19 and the Flu -
11.21.2023 Updates & Statements Antimicrobial Resistance Artificial Intelligence Medicines Wellness Listen Now: Award-Winning ‘Science Will Win’ Podcast Explores Antimicrobial Resistance -
11.16.2023 Updates & Statements Albert Bourla Business Diversity & Inclusion Leadership Pfizer CEO Albert Bourla Discusses Curing the Epidemic of Exclusion at APEC CEO Summit -
11.01.2023 Updates & Statements Albert Bourla Business Covid-19 Diversity & Inclusion Leadership Responsibility October Social Media Round-Up—Israel-Hamas War, COVID-19 Treatment News, and Pfizer Makes Forbes List
October 2023
-
10.30.2023 Updates & Statements Covid-19 Diseases & Conditions Government Pfizer's COVID-19 Oral Antiviral Treatment Transitioning from Government Distribution